BUSINESS● LOWSep 21 · Sep 21, 2026, 4:20 AM
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
CNBC · global
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS2m agoIn Mali, mining companies caught between fiscal squeeze and logistical headacheJeune AfriqueBUSINESS37m agoCan Europe beat the cost-of-living crisis? Take our poll.EuroNews [en]